Morningstar manager research analysts were busy in November, taking well over 200 U.S.-domiciled funds through the team's North American and global ratings committees. In total, we reaffirmed our views on 125 funds, upgraded 10 funds, and put seven funds under review. It was an unusual month in that no fund saw a downgrade in its rating, though three of the 61 funds newly brought under coverage received inaugural Morningstar Analyst Ratings of Negative. Below, we highlight some of the more noteworthy changes, and a table at the end summarizes all of the rating changes and additions.
We cover over 1,700 mutual funds and exchange-traded funds sold in the United States, and of those, less than 10% receive Analyst Ratings of Gold. It's notable, then, that we upgraded two funds to Gold last month. Both were from Vermont-based Champlain Investment Partners: Champlain Small Company (CIPSX) and Champlain Mid Cap (CIPMX).
Janet Yang, CFA does not own shares in any of the securities mentioned above. Find out about Morningstar's editorial policies.